Biotech · Private company · Redwood City, CA, US
Trellis Bioscience LLC
Track this companyFree. Adds Trellis Bioscience LLC to your Dealase workspace and tells you when its record changes.
Clinical trials42 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- DAIRPhase 2 · Prosthetic Joint Infections of HipClinicalTrials.gov · fetched Nov 12, 2026
- TRL1068 (calpurbatug), a human monoclonal antibodyPhase 2 · Prosthetic Joint Infections of HipClinicalTrials.gov · fetched Nov 12, 2026
- TRL1068, a human monoclonal antibodyPhase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- TRL1068, a human monoclonal antibodyPhase 1 · Prosthetic Joint InfectionClinicalTrials.gov · fetched Nov 12, 2026
- TRL345, a human monoclonal antibodyPhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Study to Evaluate Safety and Activity of Inhaled TRL1068 in Healthy VolunteersPHASE1 · NOT_YET_RECRUITING · started Oct 1, 2026ClinicalTrials.gov NCT07644195 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy and Safety of TRL1068 for the Treatment of Prosthetic Joint InfectionPHASE2 · ACTIVE_NOT_RECRUITING · started Apr 8, 2025ClinicalTrials.gov NCT06621251 · fetched Nov 12, 2026
- Study to Evaluate Safety and Activity of TRL345 in Healthy VolunteersPHASE1 · COMPLETED · started Sep 14, 2023ClinicalTrials.gov NCT05408091 · fetched Nov 12, 2026
- Study to Evaluate Safety and Activity of TRL1068 in Prosthetic Joint InfectionsPHASE1 · COMPLETED · started Feb 8, 2021ClinicalTrials.gov NCT04763759 · fetched Nov 12, 2026
NIH awards4
- Human Antibody for Acute Infection Treatment of RSVFiscal year 2026 · $999.8KNIH RePORTER 1SB1AI191674-01 · fetched Nov 12, 2026
- Bacterial Pneumonia Therapeutic Antibody Safety TrialFiscal year 2026 · $998.9KNIH RePORTER 4U44AI183920-02 · fetched Nov 12, 2026
- Bacterial Pneumonia Therapeutic Antibody Safety TrialFiscal year 2024 · $297.9KNIH RePORTER 1U44AI183920-01 · fetched Nov 12, 2026
- HCMV Therapeutic Antibody Safety TrialFiscal year 2024 · $998.1KNIH RePORTER 5U44AI152970-03 · fetched Nov 12, 2026